DEA Administrator Terrance Cole's October 2026 decision raises fundamental questions about state marijuana licenses, federal ...
Top marijuana regulators from a growing number of states are complaining that federal officials are not providing enough—or any—guidance about the Trump administration’s move to federally reschedule ...
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...
Effective April 22, 2026, the Acting Attorney General issued a final order placing certain categories of marijuana and marijuana products into Schedule III of the Controlled Substances Act (“CSA”) in ...
Doctors and telepsychiatry groups are urging the Drug Enforcement Administration to create a "special registration" pathway to enable practitioners to prescribe controlled substances via telemedicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results